These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26509454)

  • 21. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety.
    Katz N; Sun S; Johnson F; Stauffer J
    J Pain; 2010 Apr; 11(4):303-11. PubMed ID: 19944650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
    Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
    Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ; Yuan CS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Cree BA; Kornyeyeva E; Goodin DS
    Ann Neurol; 2010 Aug; 68(2):145-50. PubMed ID: 20695007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
    Portenoy RK; Thomas J; Moehl Boatwright ML; Tran D; Galasso FL; Stambler N; Von Gunten CF; Israel RJ
    J Pain Symptom Manage; 2008 May; 35(5):458-68. PubMed ID: 18440447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
    Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N
    J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alcohol on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules.
    Johnson FK; Ciric S; Boudriau S; Kisicki J; Stauffer J
    J Clin Pharmacol; 2012 May; 52(5):747-56. PubMed ID: 21593282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia.
    Cote B; Ross B; Fortner J; Rao D
    Int J Pharm Compd; 2018; 22(3):252-256. PubMed ID: 29878893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
    Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
    J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
    Younger J; Mackey S
    Pain Med; 2009; 10(4):663-72. PubMed ID: 19453963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients?
    Farahmand S; Ahmadi O; Dehpour A; Khashayar P
    Am J Emerg Med; 2012 Jan; 30(1):75-8. PubMed ID: 21075578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent blockade of OGFr and treatment of autoimmune disorders.
    Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Dec; 243(17-18):1323-1330. PubMed ID: 30541348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsules.
    Webster LR; Brewer R; Morris D; Cleveland JM; Setnik B
    Postgrad Med; 2011 Sep; 123(5):155-64. PubMed ID: 21904098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.
    Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of very low-dose naltrexone during opiate detoxification.
    Mannelli P; Gottheil E; Buonanno A; De Risio S
    J Addict Dis; 2003; 22(2):63-70. PubMed ID: 12703669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
    Katz N; Hale M; Morris D; Stauffer J
    Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.